Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $29.1B | $32.2B | $36B | $36.1B | $37.2B | |
| Revenue Growth (YoY) | 23.59% | 10.91% | 11.55% | 0.55% | 2.81% | |
| Cost of Revenues | $22.5B | $25.9B | $28.1B | $28.5B | $31.1B | |
| Gross Profit | $6.6B | $6.3B | $7.8B | $7.7B | $6.1B | |
| Gross Profit Margin | 22.7% | 19.58% | 21.74% | 21.18% | 16.36% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.9B | $2B | $2.4B | $2.5B | $2.6B | |
| Other Inc / (Exp) | $1.1B | $188.1M | $367.9M | $301.2M | -- | |
| Operating Expenses | $1.9B | $2B | $2.4B | $2.5B | $2.6B | |
| Operating Income | $4.7B | $4.3B | $5.4B | $5.1B | $3.5B | |
| Net Interest Expenses | $496.8M | $497.2M | $551M | $596.6M | $638.4M | |
| EBT. Incl. Unusual Items | $5.4B | $4.2B | $5.4B | $5B | $2.5B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.2B | $948.5M | $1.3B | $1.2B | $650.6M | |
| Net Income to Company | $4.2B | $3.3B | $4.1B | $3.8B | $1.9B | |
| Minority Interest in Earnings | $1M | $1.8M | $200K | $1.4M | $300K | |
| Net Income to Common Excl Extra Items | $4.2B | $3.3B | $4.1B | $3.8B | $1.9B | |
| Basic EPS (Cont. Ops) | $3.57 | $2.85 | $3.60 | $3.32 | $1.63 | |
| Diluted EPS (Cont. Ops) | $3.54 | $2.83 | $3.58 | $3.31 | $1.63 | |
| Weighted Average Basic Share | $1.2B | $1.2B | $1.1B | $1.1B | $1.1B | |
| Weighted Average Diluted Share | $1.2B | $1.2B | $1.2B | $1.1B | $1.1B | |
| EBITDA | $7.4B | $7.3B | $6.8B | $6.7B | $5.2B | |
| EBIT | $4.7B | $4.3B | $5.4B | $5.1B | $3.5B | |
| Revenue (Reported) | $29.1B | $32.2B | $36B | $36.1B | $37.2B | |
| Operating Income (Reported) | $4.7B | $4.3B | $5.4B | $5.1B | $3.5B | |
| Operating Income (Adjusted) | $4.7B | $4.3B | $5.4B | $5.1B | $3.5B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $8.1B | $8.4B | $9.4B | $9.1B | $9.6B | |
| Revenue Growth (YoY) | 31.34% | 3.17% | 11.48% | -3.18% | 5.47% | |
| Cost of Revenues | $6.2B | $6.8B | $7.1B | $7.2B | $8B | |
| Gross Profit | $1.9B | $1.6B | $2.3B | $1.8B | $1.6B | |
| Gross Profit Margin | 23.56% | 19.01% | 24.28% | 20.34% | 16.33% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $501.2M | $538M | $635.8M | $644.8M | $642M | |
| Other Inc / (Exp) | $929.1M | $55.5M | $119.4M | $103.4M | -- | |
| Operating Expenses | $501.2M | $538M | $635.8M | $644.8M | $642M | |
| Operating Income | $1.4B | $1.1B | $1.6B | $1.2B | $920M | |
| Net Interest Expenses | $127.4M | $124.3M | $153.8M | $152.3M | $169.1M | |
| EBT. Incl. Unusual Items | $2.2B | $1.1B | $1.6B | $1.2B | $163.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $483M | $222.7M | $373.8M | $284.1M | $30.8M | |
| Net Income to Company | $1.8B | $878.6M | $1.2B | $909.6M | $133.2M | |
| Minority Interest in Earnings | $200K | $200K | -- | $300K | -- | |
| Net Income to Common Excl Extra Items | $1.8B | $878.5M | $1.2B | $909.6M | $133.1M | |
| Basic EPS (Cont. Ops) | $1.50 | $0.77 | $1.07 | $0.80 | $0.12 | |
| Diluted EPS (Cont. Ops) | $1.49 | $0.76 | $1.06 | $0.80 | $0.12 | |
| Weighted Average Basic Share | $1.2B | $1.1B | $1.1B | $1.1B | $1.1B | |
| Weighted Average Diluted Share | $1.2B | $1.2B | $1.1B | $1.1B | $1.1B | |
| EBITDA | $2.1B | $1.8B | $2B | $1.6B | $1.4B | |
| EBIT | $1.4B | $1.1B | $1.6B | $1.2B | $920M | |
| Revenue (Reported) | $8.1B | $8.4B | $9.4B | $9.1B | $9.6B | |
| Operating Income (Reported) | $1.4B | $1.1B | $1.6B | $1.2B | $920M | |
| Operating Income (Adjusted) | $1.4B | $1.1B | $1.6B | $1.2B | $920M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $29.1B | $32.2B | $36B | $36.1B | $37.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $22.5B | $25.9B | $28.1B | $28.5B | $31.1B | |
| Gross Profit | $6.6B | $6.3B | $7.8B | $7.6B | $6.1B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.9B | $2B | $2.4B | $2.5B | $2.6B | |
| Other Inc / (Exp) | $1.1B | $188.1M | $367.9M | $301.2M | -- | |
| Operating Expenses | $1.9B | $2B | $2.4B | $2.5B | $2.6B | |
| Operating Income | $4.7B | $4.3B | $5.4B | $5.1B | $3.5B | |
| Net Interest Expenses | $493.4M | $497.1M | $551M | $596.6M | $638.4M | |
| EBT. Incl. Unusual Items | $5.4B | $4.2B | $5.4B | $5B | $2.5B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.2B | $948.6M | $1.3B | $1.2B | $650.6M | |
| Net Income to Company | $4.2B | $3.3B | $4.1B | $3.8B | $1.9B | |
| Minority Interest in Earnings | $1M | $1.7M | $200K | $1.3M | $200K | |
| Net Income to Common Excl Extra Items | $4.2B | $3.3B | $4.1B | $3.8B | $1.9B | |
| Basic EPS (Cont. Ops) | $3.56 | $2.85 | $3.60 | $3.32 | $1.63 | |
| Diluted EPS (Cont. Ops) | $3.54 | $2.83 | $3.58 | $3.31 | $1.63 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $7.4B | $7.3B | $7.8B | $6.7B | $5.2B | |
| EBIT | $4.7B | $4.3B | $5.4B | $5.1B | $3.5B | |
| Revenue (Reported) | $29.1B | $32.2B | $36B | $36.1B | $37.2B | |
| Operating Income (Reported) | $4.7B | $4.3B | $5.4B | $5.1B | $3.5B | |
| Operating Income (Adjusted) | $4.7B | $4.3B | $5.4B | $5.1B | $3.5B | |
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2026-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $32.2B | $36B | $36.1B | $37.2B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $25.9B | $28.1B | $28.5B | $31.1B | -- | |
| Gross Profit | $6.3B | $7.8B | $7.6B | $6.1B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2B | $2.4B | $2.5B | $2.6B | -- | |
| Other Inc / (Exp) | $188.1M | $367.9M | $301.2M | $25.7M | -- | |
| Operating Expenses | $2B | $2.4B | $2.5B | $2.6B | -- | |
| Operating Income | $4.3B | $5.4B | $5.1B | $3.5B | -- | |
| Net Interest Expenses | $497.1M | $551M | $596.6M | $638.4M | -- | |
| EBT. Incl. Unusual Items | $4.2B | $5.4B | $5B | $2.5B | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $948.6M | $1.3B | $1.2B | $650.6M | -- | |
| Net Income to Company | $3.3B | $4.1B | $3.8B | $1.9B | -- | |
| Minority Interest in Earnings | $1.7M | $200K | $1.3M | $200K | -- | |
| Net Income to Common Excl Extra Items | $3.3B | $4.1B | $3.8B | $1.9B | -- | |
| Basic EPS (Cont. Ops) | $2.85 | $3.60 | $3.32 | $1.63 | -- | |
| Diluted EPS (Cont. Ops) | $2.83 | $3.58 | $3.31 | $1.63 | -- | |
| Weighted Average Basic Share | $4.6B | $4.6B | $4.5B | $4.5B | -- | |
| Weighted Average Diluted Share | $4.6B | $4.6B | $4.5B | $4.6B | -- | |
| EBITDA | $7.3B | $7.8B | $6.7B | $5.2B | -- | |
| EBIT | $4.3B | $5.4B | $5.1B | $3.5B | -- | |
| Revenue (Reported) | $32.2B | $36B | $36.1B | $37.2B | -- | |
| Operating Income (Reported) | $4.3B | $5.4B | $5.1B | $3.5B | -- | |
| Operating Income (Adjusted) | $4.3B | $5.4B | $5.1B | $3.5B | -- | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $6.6B | $3.2B | $4B | $3.5B | $3.5B | |
| Short Term Investments | $162.2M | $364.5M | $401.5M | $257M | -- | |
| Accounts Receivable, Net | $940M | $1.2B | $1.2B | $1.2B | $1.3B | |
| Inventory | $1.6B | $2.2B | $1.8B | $1.8B | $2.2B | |
| Prepaid Expenses | $401.5M | -- | -- | -- | -- | |
| Other Current Assets | -- | $483.7M | $359.9M | $313.1M | -- | |
| Total Current Assets | $9.8B | $7B | $7.3B | $6.8B | $7.4B | |
| Property Plant And Equipment | $14.6B | $14.6B | $15.8B | $18B | $17.8B | |
| Long-Term Investments | $634.5M | $746.5M | $840.3M | $919M | $991.7M | |
| Goodwill | $3.7B | $3.3B | $3.2B | $3.3B | -- | |
| Other Intangibles | $349.9M | $155.9M | $120.5M | $100.9M | -- | |
| Other Long-Term Assets | $578.5M | $554.2M | $546.5M | $617M | -- | |
| Total Assets | $31.4B | $28B | $29.4B | $31.3B | $32B | |
| Accounts Payable | $1.2B | $1.4B | $1.5B | $1.6B | $1.9B | |
| Accrued Expenses | $1.7B | $1.7B | $1.7B | $1.7B | -- | |
| Current Portion Of Long-Term Debt | $998.9M | $1.9B | $1.9B | $1.2B | -- | |
| Current Portion Of Capital Lease Obligations | $1.3B | $1.2B | $1.3B | $1.5B | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $8.2B | $9.2B | $9.3B | $9.1B | $10.2B | |
| Long-Term Debt | $21.4B | $20.6B | $21.5B | $23.1B | $23.5B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $36.7B | $36.7B | $37.4B | $38.8B | $40.1B | |
| Common Stock | $1.2M | $1.1M | $1.1M | $1.1M | $1.1M | |
| Other Common Equity Adj | $147.2M | -$463.2M | -$778.2M | -$428.8M | -- | |
| Common Equity | -$5.3B | -$8.7B | -$8B | -$7.4B | -$8.1B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $6.7M | $7.9M | $7M | $7.3M | $7.4M | |
| Total Equity | -$5.3B | -$8.7B | -$8B | -$7.4B | -$8.1B | |
| Total Liabilities and Equity | $31.4B | $28B | $29.4B | $31.3B | $32B | |
| Cash and Short Terms | $6.6B | $3.2B | $4B | $3.5B | $3.5B | |
| Total Debt | $22.4B | $22.4B | $23.3B | $24.3B | $25B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $6.6B | $3.2B | $4B | $3.5B | $3.5B | |
| Short Term Investments | $162.2M | $364.5M | $401.5M | $257M | -- | |
| Accounts Receivable, Net | $940M | $1.2B | $1.2B | $1.2B | $1.3B | |
| Inventory | $1.6B | $2.2B | $1.8B | $1.8B | $2.2B | |
| Prepaid Expenses | $401.5M | -- | -- | -- | -- | |
| Other Current Assets | -- | $483.7M | $359.9M | $313.1M | -- | |
| Total Current Assets | $9.8B | $7B | $7.3B | $6.8B | $7.4B | |
| Property Plant And Equipment | $14.6B | $14.6B | $15.8B | $18B | $17.8B | |
| Long-Term Investments | $634.5M | $746.5M | $840.3M | $919M | $991.7M | |
| Goodwill | $3.7B | $3.3B | $3.2B | $3.3B | -- | |
| Other Intangibles | $349.9M | $155.9M | $120.5M | $100.9M | -- | |
| Other Long-Term Assets | $578.5M | $554.2M | $546.5M | $617M | -- | |
| Total Assets | $31.4B | $28B | $29.4B | $31.3B | $32B | |
| Accounts Payable | $1.2B | $1.4B | $1.5B | $1.6B | $1.9B | |
| Accrued Expenses | $1.7B | $1.7B | $1.7B | $1.7B | -- | |
| Current Portion Of Long-Term Debt | $998.9M | $1.9B | $1.9B | $1.2B | -- | |
| Current Portion Of Capital Lease Obligations | $1.3B | $1.2B | $1.3B | $1.5B | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $8.2B | $9.2B | $9.3B | $9.1B | $10.2B | |
| Long-Term Debt | $21.4B | $20.6B | $21.5B | $23.1B | $23.5B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $36.7B | $36.7B | $37.4B | $38.8B | $40.1B | |
| Common Stock | $1.2M | $1.1M | $1.1M | $1.1M | $1.1M | |
| Other Common Equity Adj | $147.2M | -$463.2M | -$778.2M | -$428.8M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $6.7M | $7.9M | $7M | $7.3M | $7.4M | |
| Total Equity | -$5.3B | -$8.7B | -$8B | -$7.4B | -$8.1B | |
| Total Liabilities and Equity | $31.4B | $28B | $29.4B | $31.3B | $32B | |
| Cash and Short Terms | $6.6B | $3.2B | $4B | $3.5B | $3.5B | |
| Total Debt | $22.4B | $22.4B | $23.3B | $24.3B | $25B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $4.2B | $3.3B | $4.1B | $3.8B | $1.9B | |
| Depreciation & Amoritzation | $2.8B | $3B | $1.5B | $1.6B | $1.8B | |
| Stock-Based Compensation | $319.1M | $271.5M | $302.7M | $308.3M | $318.3M | |
| Change in Accounts Receivable | -$43M | -$326.1M | -$4.1M | $18.4M | -$89.7M | |
| Change in Inventories | -$49.8M | -$641M | $366.4M | $42.8M | -$408.4M | |
| Cash From Operations | $6B | $4.4B | $6B | $6.1B | $4.7B | |
| Capital Expenditures | $1.5B | $1.8B | $2.3B | $2.8B | $2.3B | |
| Cash Acquisitions | -- | -- | -- | -- | $177.1M | |
| Cash From Investing | -$319.5M | -$2.1B | -$2.3B | -$2.7B | -$2.5B | |
| Dividends Paid (Ex Special Dividend) | $2.1B | $2.3B | $2.4B | $2.6B | $2.8B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $215.1M | $1.7B | $1.6B | $2.1B | -- | |
| Long-Term Debt Repaid | -$1.9B | -$1B | -$1.3B | -$2B | -- | |
| Repurchase of Common Stock | -- | $4B | $984.4M | $1.3B | -- | |
| Other Financing Activities | -$97M | -$136.4M | -$100.4M | -$111M | -- | |
| Cash From Financing | -$3.7B | -$5.6B | -$3B | -$3.7B | -$2.3B | |
| Beginning Cash (CF) | $6.5B | $2.8B | $3.6B | $3.3B | $3.2B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.1B | -$3.6B | $733.1M | -$265.3M | -$66.4M | |
| Ending Cash (CF) | $8.6B | -$1.1B | $4.3B | $3.1B | $3.1B | |
| Levered Free Cash Flow | $4.5B | $2.6B | $3.7B | $3.3B | $2.4B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.8B | $878.6M | $1.2B | $909.6M | $133.2M | |
| Depreciation & Amoritzation | $694.8M | $767.7M | -$621.9M | $401.4M | $456M | |
| Stock-Based Compensation | $63.8M | $64.9M | $74.2M | $71.7M | $74M | |
| Change in Accounts Receivable | -$29.9M | -$80.6M | -$48.4M | -$26.3M | -$43.3M | |
| Change in Inventories | -$58.2M | -$83.7M | $171.9M | $96.2M | $69.2M | |
| Cash From Operations | $1.5B | $1.1B | $1.9B | $1.5B | $1.4B | |
| Capital Expenditures | $484.3M | $545.9M | $699.5M | $798.2M | $456M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $666.7M | -$770M | -$864.6M | -$849.7M | -$390.5M | |
| Dividends Paid (Ex Special Dividend) | $530.8M | $562.2M | $607M | $646M | $693.3M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -$500K | -$27.3M | $30.9M | $5.5M | -- | |
| Long-Term Debt Repaid | -$3.6M | $2.3M | -$32.1M | -$30.5M | -- | |
| Repurchase of Common Stock | -- | -- | $285.1M | -- | -- | |
| Other Financing Activities | -$2.8M | -$3.7M | -$2.4M | -$2.3M | -- | |
| Cash From Financing | -$483.1M | -$564.8M | -$877.7M | -$644.5M | -$1.9B | |
| Beginning Cash (CF) | $6.5B | $2.8B | $3.6B | $3.3B | $3.2B | |
| Foreign Exchange Rate Adjustment | -$1.7M | -$124M | -$8.2M | $65.7M | -$11.3M | |
| Additions / Reductions | $1.7B | -$359.1M | $194.5M | $107.1M | -$952.8M | |
| Ending Cash (CF) | $8.2B | $2.3B | $3.7B | $3.5B | $2.3B | |
| Levered Free Cash Flow | $1B | $553.8M | $1.2B | $737.4M | $925.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $4.2B | $3.3B | $4.1B | $3.8B | $1.9B | |
| Depreciation & Amoritzation | $2.8B | $3B | $1.5B | $1.6B | $1.8B | |
| Stock-Based Compensation | $319.1M | $271.5M | $302.7M | $308.3M | $318.3M | |
| Change in Accounts Receivable | -$43M | -$326.1M | -$4.1M | $18.4M | -$89.7M | |
| Change in Inventories | -$49.8M | -$641M | $366.4M | $42.8M | -$408.4M | |
| Cash From Operations | $6B | $4.4B | $6B | $6.1B | $4.7B | |
| Capital Expenditures | $1.5B | $1.8B | $2.3B | $2.8B | $2.3B | |
| Cash Acquisitions | -- | -- | -- | -- | $177.1M | |
| Cash From Investing | -$319.5M | -$2.1B | -$2.3B | -$2.7B | -$2.5B | |
| Dividends Paid (Ex Special Dividend) | $2.1B | $2.3B | $2.4B | $2.6B | $2.8B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $215.1M | -- | $1.6B | $2.1B | -- | |
| Long-Term Debt Repaid | -$1.9B | -- | -$1.3B | -$2B | -- | |
| Repurchase of Common Stock | -- | $4B | $984.4M | $1.3B | -- | |
| Other Financing Activities | -$97M | -$136.4M | -$100.4M | -$111M | -- | |
| Cash From Financing | -$3.7B | -$5.6B | -$3B | -$3.7B | -$2.3B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.1B | -$3.6B | $733.1M | -$265.3M | -$66.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $4.5B | $2.6B | $3.7B | $3.3B | $2.4B | |
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2026-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $3.3B | $4.1B | $3.8B | $1.9B | -- | |
| Depreciation & Amoritzation | $3B | $1.5B | $1.6B | $1.8B | -- | |
| Stock-Based Compensation | $271.5M | $302.7M | $308.3M | $318.3M | -- | |
| Change in Accounts Receivable | -$326.1M | -$4.1M | $18.4M | -$89.7M | -- | |
| Change in Inventories | -$641M | $366.4M | $42.8M | -$408.4M | -- | |
| Cash From Operations | $4.4B | $6B | $6.1B | $4.7B | -- | |
| Capital Expenditures | $1.8B | $2.3B | $2.8B | $2.3B | -- | |
| Cash Acquisitions | -- | -- | -- | $177.1M | -- | |
| Cash From Investing | -$2.1B | -$2.3B | -$2.7B | -$2.5B | -- | |
| Dividends Paid (Ex Special Dividend) | $2.3B | $2.4B | $2.6B | $2.8B | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.7B | $1.6B | $2.1B | $1.8B | -- | |
| Long-Term Debt Repaid | -$1B | -$1.3B | -$2B | -$7.8M | -- | |
| Repurchase of Common Stock | $4B | $984.4M | $1.3B | -- | -- | |
| Other Financing Activities | -$136.4M | -$100.4M | -$111M | -$89.8M | -- | |
| Cash From Financing | -$5.6B | -$3B | -$3.7B | -$2.3B | -- | |
| Beginning Cash (CF) | $13.9B | $13.2B | $12.2B | $13.7B | -- | |
| Foreign Exchange Rate Adjustment | -$250.3M | -$14.2M | $56.5M | -$30.5M | -- | |
| Additions / Reductions | -$3.6B | $733.1M | -$265.3M | -$66.4M | -- | |
| Ending Cash (CF) | $10B | $13.9B | $12B | $13.6B | -- | |
| Levered Free Cash Flow | $2.6B | $3.7B | $3.3B | $2.4B | -- | |
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.